Created at 9:11 p.m. Aug, 03, 2025
Author: adavis98
Related Note: 1488847766303 2
Rationale for change

Drug was discontinued and taken off market in 2019
Source: Other - https://pubmed.ncbi.nlm.nih.gov/29489145/

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Cardiology::24_Myocardial_Infarction::06_Management #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::06_Antiplatelets::*Glycoprotein_IIb/IIIa_Inhibitors #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#UWorld::COMLEX::24190 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::05_Antiplatelet_Medications #AK_Step1_v12::#NinjaNerd::09_Hematology::01_Physiology::07_Hemostasis:_Coagulation_Cascade #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::01_Antiplatelet_Medications_(MOA,_Indications,_AR,_CI) #AK_Other::Only_Step_1 #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::07_Glycoprotein_IIb/IIIa_Ihibitors #AK_Step1_v12::#NBME::28 #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies #AK_Step1_v12::#UWorld::Step::1079 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::15_Antiplatelets,_Anticoagulants,_and_Thrombolytics #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::02_Other_applications::*Abciximab #AK_Step1_v12::#NBME::29 #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::08_Glycoprotein_IIb/IIIa_Inhibitors #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_agents #AK_Step1_v12::#Physeo::^physeo_image_update